Biotechnology in Canada

Introduction

Biotechnology in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.

*The Canadian biotechnology market had total revenue of $2,863.2 million in 2010, representing a compound annual rate of change (CARC) of -11% between 2006 and 2010.

*Medical/Healthcare sales proved the most lucrative for the Canadian biotechnology market in 2010, with total revenues of $1,960.2 million, equivalent to 68.5% of the market's overall value.

*The performance of the market is forecast to accelerate, with an anticipated CAGR of 28.5% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $10,043 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Canada

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Canada

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Canada biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Canada economy

Key Questions Answered

What was the size of the Canada biotechnology market by value in 2010?

What will be the size of the Canada biotechnology market in 2015?

What factors are affecting the strength of competition in the Canada biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Canada's biotechnology market?
[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Substitutes 17
Rivalry 18
LEADING COMPANIES 19
Amgen 19
Baxter International Inc 23
Covance Inc. 26
MDS Financial Group Limited 30
MARKET FORECASTS 33
Market value forecast 33
MACROECONOMIC INDICATORS 34
APPENDIX 36
Methodology 36
Industry associations 37
Related Datamonitor research 37
Disclaimer 38
ABOUT DATAMONITOR 39
Premium Reports 39
Summary Reports 39
Datamonitor consulting 39

LIST OF TABLES
Table 1: Canada biotechnology market value: $ million, 2006–10 10
Table 2: Canada biotechnology market segmentation I:% share, by value, 2010 11
Table 3: Canada biotechnology market segmentation II: % share, by value, 2010 12
Table 4: Amgen: key facts 19
Table 5: Amgen: key financials ($) 20
Table 6: Amgen: key financial ratios 21
Table 7: Baxter International Inc: key facts 23
Table 8: Baxter International Inc: key financials ($) 24
Table 9: Baxter International Inc: key financial ratios 24
Table 10: Covance Inc.: key facts 26
Table 11: Covance Inc.: key financials ($) 27
Table 12: Covance Inc.: key financial ratios 28
Table 13: MDS Financial Group Limited: key facts 30
Table 14: MDS Financial Group Limited: key financials ($) 31
Table 15: MDS Financial Group Limited: key financial ratios 31
Table 16: Canada biotechnology market value forecast: $ million, 2010–15 33
Table 17: Canada size of population (million), 2006–10 34
Table 18: Canada gdp (constant 2000 prices, $ billion), 2006–10 34
Table 19: Canada gdp (current prices, $ billion), 2006–10 34
Table 20: Canada inflation, 2006–10 35
Table 21: Canada consumer price index (absolute), 2006–10 35
Table 22: Canada exchange rate, 2006–10 35

LIST OF FIGURES
Figure 1: Canada biotechnology market value: $ million, 2006–10 10
Figure 2: Canada biotechnology market segmentation I:% share, by value, 2010 11
Figure 3: Canada biotechnology market segmentation II: % share, by value, 2010 12
Figure 4: Forces driving competition in the biotechnology market in Canada, 2010 13
Figure 5: Drivers of buyer power in the biotechnology market in Canada, 2010 14
Figure 6: Drivers of supplier power in the biotechnology market in Canada, 2010 15
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Canada, 2010 16
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Canada, 2010 17
Figure 9: Drivers of degree of rivalry in the biotechnology market in Canada, 2010 18
Figure 10: Amgen: revenues & profitability 21
Figure 11: Amgen: assets & liabilities 22
Figure 12: Baxter International Inc: revenues & profitability 25
Figure 13: Baxter International Inc: assets & liabilities 25
Figure 14: Covance Inc.: revenues & profitability 28
Figure 15: Covance Inc.: assets & liabilities 29
Figure 16: MDS Financial Group Limited: revenues & profitability 32
Figure 17: MDS Financial Group Limited: assets & liabilities 32
Figure 18: Canada biotechnology market value forecast: $ million, 2010–15 33


[Inhaltsverzeichnis ausblenden]